Genetic analysis of influenza A/H3N2 and A/H1N1 viruses circulating in Vietnam from 2001 to 2006

Journal of Clinical Microbiology

Volumn 46, Issue 2, 2008, Pages 399-405

  Li, Danjuan ^a   Saito, Reiko ^a   Le, Mai T Q ^b   Nguyen, Hang L K ^b   Suzuki, Yasushi ^a   Shobugawa, Yugo ^a   Dinh, Due T ^b   Hoang, Phuong V M ^b   Tran, Huong T T ^b   Nghiem, Ha K ^b   Hoang, Long T ^b   Huynh, Lien P ^b   Nguyen, Hien T ^b   Nishikawa, Makoto ^c   Suzuki, Hiroshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^c Niigata Prefectural Institute of Public Health And Environmental Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; MATRIX PROTEIN; SIALIDASE;

ARTICLE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DRIFT; GENETIC REASSORTMENT; HA GENE; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; M GENE; NA GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIET NAM; VIRUS GENE; VIRUS STRAIN;

ANTIGENS, VIRAL; EPITOPES; EVOLUTION, MOLECULAR; GENETIC DRIFT; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; PHYLOGENY; REASSORTANT VIRUSES; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; VIETNAM; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 38949166034     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01549-07     Document Type: Article

References (44)

1. Barr, I. G., A. C. Hurt, P. Iannello, C. Tomasov, N. Deed, and N. Komadina. 2007. Increased amantadine resistance in influenza A (H3) viruses in Australia and neighboring countries in 2005. Antivir. Res. 73:112-117.
2. Beckett, C. G., H. Kosasih, C. Ma'roef, E. Listiyaningsih, I. R. Q. Elyazar, S. Wuryadi, D. Yuwono, J. L. McArdle, A. L. Corwin, and K. R. Porter. 2004. Influenza surveillance in Indonesia: 1999-2003. Clin. Infect. Dis. 39:443-449.
3. Besselaar, T. G., L. Botha, J. M. McAnerney, and B. D. Schoub. 2004. Antigenic and molecular analysis of influenza A (H3N2) virus strain isolated from a localized influenza outbreak in South Africa in 2003. J. Med. Virol. 73:71-78.
4. Bright, R. A., M. J. Medina, X. Xu, G. P. Oronoz, T. R. Wallis, X. M. Davis, L. Povinelli, N. Cox, and A. I. Klimov. 2005. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366:1175-1181.
5. Bright, R. A., D. K. Shay, B. Shu, N. J. Cox, and A. I. Klimov. 2006. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295:891-894.
6. Buonagurio, D. A., S. Nakada, J. D. Parvin, M. Krystal, P. Palese, and W. M. Fitch. 1986. Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene. Science 232:980-982.
7. Caton, A., G. G. Brownlee, J. W. Yewell, and W. Gerhard. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427.
8. Center for Disease Control. 1982. Concepts and procedures for laboratory based influenza surveillance. Center for Disease Control, Atlanta, GA.
9. Chi, X. S., T. V. Bolar, P. Zhao, J. S. Tam, R. Rappaport, and S. M. Cheng. 2005. Molecular evolution of human influenza A/H3N2 virus in Asia and Europe from 2001 to 2003. J. Clin. Microbiol. 43:6130-6132.
10. Cox, N. J., Z. S. Bai, and A. P. Kendal. 1983. Laboratory-based surveillance of influenza A (H1N1) and A (H3N2) viruses in 1980-81: antigenic and genomic analyses. Bull. W. H. O. 61:143-152.
11. Daum, L. T., M. W. A. Shaw, I. Klimov, L. C. Canas, E. A. Macias, D. Niemeyer, J. P. Chambers, R. Renthal, S. K. Shrestha, R. P. Acharya, S. P. Huzdar, N. Rimai, K. S. Myint, and P. Gould. 2005. Influenza A (H3N2) outbreak, Nepal. Emerg. Infect. Dis. 11:1186-1191.
12. Deyde, V. M., X. Xu, R. A. Bright, M. Shaw, C. B. Smith, Y. Zhang, Y. Shu, L. V. Gubareva, N. J. Cox, and A. I. Klimov. 2007. Surveillance of resistance to adamantanes among influenza A (H3N2) and A (H1N1) viruses isolated worldwide. J. Infect. Dis. 196:249-257.
13. Ellis, J. S., A. Alvarez-Aguero, V. Gregory, Y. P. Lin, A. Hay, and M. C. Zambon. 2003. Influenza A (H1N2) viruses and their impact during the 2001-02 influenza season in the United Kingdom. Emerg. Infect. Dis. 9:304-310.
14. Enami, K., Y. Qiao, R. Fukuda, and M. Enami. 1993. An influenza virus temperature-sensitive mutant defective in the nuclear-cytoplasmic transport of the negative-sense viral RNAs. Virology 194:822-827.
15. Ferguson, N. M., A. P. Galvani, and R. M. Bush. 2003. Ecological and immunological determinants of influenza evolution. Nature 422:428-433.
16. Fitch, W. M., R. M. Bush, C. A. Bender, and N. J. Cox. 1997. Long term trends in the evolution of H (3) HA1 human influenza type A. Proc. Natl. Acad. Sci. USA 94:7712-7718.
17. Fitch, W. M., R. M. Bush, C. A. Bender, K. Subbarao, and N. J. Cox. 2000. Predicting the evolution of human influenza A. J. Hered. 91:183-185.
18. Gachara, G., J. Ngeranwa, J. M. Magana, J. M. Simwa, P. W. Wango, S. M. Lifumo, and E. O. Ochieng. 2006. Influenza virus strains in Nairobi, Kenya. J. Clin. Virol. 35:117-118.
19. Gregory, V., M. Bennett, M. H. Orkhan, A. I. Hajjar, N. Varsano, E. Mendelson, M. Zambon, J. Ellis, A. Hay, and Y. P. Lin. 2002. Emergence of influenza A H1N2 reassortant viruses in the human population during 2001. Virology 300:1-7.
20. Hampson, A. W. 1999. Epidemiological data on influenza in Asian countries. Vaccine 17(Suppl. 1):S19-S23.
21. Hang, L. K. N., R. Saito, K. N. Ha, M. Nishikawa, Y. Shobugawa, C. N. Doan, T. H. Long, P. H. Lien, and H. Suzuki. 2007. Epidemiology of influenza in Hanoi, Vietnam, from 2001 to 2003. J. Infect. 55:58-63.
22. Hay, A. J., and Y. Lin. 2005. Characteristics of human influenza A H1N1, A H3N2 and B viruses isolated February to July 2005. WHO Influenza Centre, London, United Kingdom.
23. Hay, A. J., A. J. Wolstenholme, J. J. Skehel, and M. H. Smith. 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4:3021-3024.
24. Hoffmann, E., J. Stech, Y. Guan, R. G. Webster, and D. R. Perez. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146:2275-2289.
25. Holmes, E. C., E. Ghedin, N. Miller, J. Taylor, Y. Bao, K. S. George, B. T. Grenfell, S. L. Salzberg, C. M. Fraster, D. J. Lipman, and J. K. Taubenberger. 2005. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol. 3:1579-1588.
26. Kumar, S., K. Tamura, and M. Nei. 2004. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5:150-163.
27. Li, C. K., B. C. Choi, and T. W. Wong. 2006. Influenza related deaths and hospitalizations in Hong Kong: a subtropical area. Public Health 120:517-524.
28. Lin, Y. P., V. Gregory, M. Bennett, and A. Hay. 2004. Recent changes among human influenza viruses. Virus Res. 103:47-52.
29. Lindstrom, S. E., Y. Hiromoto, R. Nerome, K. Omoe, S. Sugita, Y. Yamazaki, T. Takahashi, and K. Nerome. 1998. Phylogenetic analysis of the entire genome of influenza A (H3N2) viruses from Japan: evidence for genetic reassortment of the six internal genes. J. Virol. 72:8021-8031.
30. Macken, C., H. Lu, J. Goodman, and L. Boykin. 2001. The value of a database in surveillance and vaccine selection, p. 103-106. In A. D. M. E. Osterhaus, N. Cox, and A. W. Hampson (ed.), Options for the control of influenza IV. Elsevier Science, Amsterdam, The Netherlands.
31. Mar, A., R. Rahmanian, V. Lei, D. Lawrence, M. Krajden, R. C. Brunham, D. Skowronski, Y. Li, T. Booth, S. H. Goh, and M. Petric. 2006. Longitudinal analysis of genotype distribution of influenza A virus from 2003 to 2005. J. Clin. Microbiol. 44:3583-3588.
32. Nishikawa, F., and T. Sugiyama. 1983. Direct isolation of H1N2 recombinant virus from a throat swab of a patient simultaneously infected with H1N1 and H3N2 influenza A viruses. J. Clin. Microbiol. 18:425-427.
33. Reid, A. H., T. G. Fanning, T. A. Janczewski, and J. K. Taubenberger. 2000. Characterization of the 1918 Spanish influenza virus neuraminidase gene. Proc. Natl. Acad. Sci. USA 97:6785-6790.
34. Saito, R., D. Li, C. Shimomura, H. Masaki, Q. E. Mai, L. K. N. Hang, T. N. Hien, T. N. Tien, V. P. Tu, T. K. N. Tien, M. Sato, Y. Suzuki, and Y. Suzuki. 2006. An off-seasonal amantadine resistant H3N2 influenza outbreak in Japan. Tohoku J. Exp. Med. 210:21-27.
35. Saito, R., D. Li, and H. Suzuki. 2007. Amantadine-resistant influenza A (H3N2) virus in Japan, 2005-2006. N. Engl. J. Med. 356:312-313.
36. Smeenk, C. A., and E. G. Brown. 1994. The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J. Virol. 68:530-534.
37. Smith, D. J., A. S. Lapedes, J. C. de Jong, T. M. Bestebroer, G. F. Rimmelzwaan, A. D. Osterhaus, and R. A. Fouchier. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376.
38. Wiley, D. C., I. A. Wilson, and J. J. Skehel. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza hemagglutinin and their involvement in antigenic variation. Nature 289:373-378.
39. Wilson, I. A., and N. J. Cox. 1990. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 8:737-771.
40. World Health Organization. 2004. Recommended composition of influenza virus vaccines for use in the 2004-2005 influenza season. Wkly. Epidemiol. Rec. 79:88-92.
41. World Health Organization. 2007. Recommended composition of influenza virus vaccines for use in the 2007-2008 influenza season. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/disease/influenza/ vaccinerecommendations/en/index.html.
42. Xu, X., C. B. Smith, B. A. Mungall, S. E. Lindstrom, H. E. Hall, K. Subbarao, N. J. Cox, and A. Klimov. 2002. Intercontinental circulation of human influenza A (H1N2) reassortant viruses during the 2001-2002 influenza season. J. Infect. Dis. 186:490-493.
43. Yasuda, J., D. J. Bucher, and A. Ishihama. 1994. Growth control of influenza A virus by M1 protein: analysis of transfectant viruses carrying the chimeric M gene. J. Virol. 68:8141-8146.
44. Yasuda, J., T. Toyoda, M. Nakayama, and A. Ishihama. 1993. Regulatory effects of matrix protein variations on influenza virus growth. Arch. Virol. 133:283-294.